InvestorsHub Logo
Followers 79
Posts 24457
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 06/13/2017 8:21:46 AM

Tuesday, June 13, 2017 8:21:46 AM

Post# of 27361
MBRX - .80


Moleculin Announces Preparation to File an IND with the FDA for WP1220 for Treatment of Cutaneous T-Cell Lymphoma



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.